Chisholm Karen M, Ohgami Robert S, Tan Brent, Hasserjian Robert P, Weinberg Olga K
Department of Pathology, Boston Children's Hospital, Boston, MA 02115, USA.
Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Hum Pathol. 2017 Feb;60:1-10. doi: 10.1016/j.humpath.2016.07.028. Epub 2016 Aug 20.
Primary lymphoma of bone (PLB) accounts for 3% to 7% of primary neoplasms of bone and must be distinguished from more common bone tumors in the pediatric population such as osteosarcoma, Ewing sarcoma, and other small round blue cell tumors. In this study, pathology databases from 4 institutions were queried for PLB in individuals 1 to 21 years old. A total of 54 cases of PLB were identified, including 41 diffuse large B-cell lymphomas (DLBCL, 76%), 8 B-lymphoblastic lymphomas (BLL, 15%), 3 anaplastic large cell lymphomas (ALCL, 6%), and 2 low-grade follicular lymphomas (4%). The male/female ratio was 1.8:1 and median age was 16 years (range, 2-21). Patients with DLBCL were significantly older (P<.001), and patients with ALCL and BLL were significantly younger (P=.050 and P=.008, respectively) when compared with the other patients. Due to necrosis, crush artifact, and/or insufficient material, 30% of cases required multiple biopsies for diagnosis. The femur, tibia, pelvic bones, humerus, and vertebrae were most commonly involved. DLBCL patients had significantly more solitary bone involvement (P=.001), whereas BLL had significantly more polyostotic involvement (P<.001). Of the 37 patients with outcome data, all had no evidence of disease on last follow-up. This largest pediatric series of PLB identifies DLBCL as the most frequent subtype and documents rarer occurrences of BLL, ALCL, and follicular lymphomas. The differential diagnosis of bone neoplasms in pediatric patients, including those with necrosis, should include PLB.
骨原发性淋巴瘤(PLB)占原发性骨肿瘤的3%至7%,必须与儿科人群中更常见的骨肿瘤如骨肉瘤、尤因肉瘤和其他小圆蓝细胞肿瘤相鉴别。在本研究中,查询了4家机构的病理数据库,以获取1至21岁个体的PLB病例。共识别出54例PLB,包括41例弥漫性大B细胞淋巴瘤(DLBCL,76%)、8例B淋巴母细胞淋巴瘤(BLL,15%)、3例间变性大细胞淋巴瘤(ALCL,6%)和2例低级滤泡性淋巴瘤(4%)。男女比例为1.8:1,中位年龄为16岁(范围2至21岁)。与其他患者相比,DLBCL患者年龄显著更大(P<0.001),而ALCL和BLL患者年龄显著更小(分别为P=0.050和P=0.008)。由于坏死、挤压假象和/或材料不足,30%的病例需要多次活检才能确诊。股骨、胫骨、骨盆骨、肱骨和椎骨是最常受累的部位。DLBCL患者单骨受累明显更多(P=0.001),而BLL多骨受累明显更多(P<0.001)。在有结局数据的37例患者中,所有患者在最后一次随访时均无疾病证据。这一最大的儿科PLB系列研究确定DLBCL为最常见的亚型,并记录了BLL、ALCL和滤泡性淋巴瘤的罕见病例。儿科患者骨肿瘤的鉴别诊断,包括有坏死的患者,应包括PLB。